Johnson& Johnson vaccine may be ready by the beginning of year 2021
The American pharmaceutical and chemical company Johnson& Johnson (J&J) starts testing its experimental coronavirus vaccine on 60,000 subjects. The vaccine is developed by its subsidiary Janssen in Leiden.
It is a single dose of the vaccine being tested. The first results are expected to be released by the end of this year and a vaccine should be ready for emergency use by the beginning of next year.
The tests are performed on subjects in the United States, South America and South Africa. According to J&J, a proportionately large number of people over the age of 60 will be tested because they are more at risk of serious forms of Covid-19. In addition, many people in the US are also being tested with African-American, Latin-American and indigenous-American backgrounds, because these populations are hit relatively hard by the pandemic.
Other companies working on a possible vaccine against the coronavirus include Moderna, Pfizer and AstraZeneca.